Biostarks

  • Home
  • About
Sign in Subscribe

Latest

The race to biomarkers — but are we measuring the right ones?

The race to biomarkers — but are we measuring the right ones?

More is not always better. A look at what the at-home testing market is actually selling, what it's missing, and what a rational panel should look like. This is the third piece in the Late Night Convo series. The first was about how we rebuilt Biostarks as
Romain Dorange 01 May 2026
Reading the at-home biomarker M&A wave

Reading the at-home biomarker M&A wave

Romain Dorange 23 Apr 2026
Making Biostarks an AI native at-home biomarker testing company

Making Biostarks an AI native at-home biomarker testing company

Romain Dorange 12 Apr 2026
Hello, World.

Hello, World.

Romain Dorange 12 Apr 2026

News

Hello, World.

Hello, World.

This is Thought Leadership on Building Biostarks. Things will be up and running here shortly, but you can subscribe in the meantime if you'd like to stay up to date and receive emails when new content is published!
Romain Dorange 12 Apr 2026
Show more

Subscribe to Biostarks

Don't miss out on the latest news. Sign up now to get access to the library of members-only articles.
  • Sign up
Biostarks © 2026. Powered by Ghost